
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
over 24 years ago
Current Indications for ACE Inhibitors and HOPE for the Futureover 24 years ago
Is Quality Free? It Depends




